Your session is about to expire
← Back to Search
Behavioral Intervention
DREAM Intervention for Type 1 Diabetes (DREAM Trial)
N/A
Waitlist Available
Led By Jenise C Wong, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months
Awards & highlights
Summary
"This trial aims to help Latinx adolescents with type 1 diabetes in California improve their glucose control by developing a virtual peer group intervention called DREAM. The intervention will focus on encouraging and supporting the use
Who is the study for?
This trial is for Latinx adolescents with Type 1 Diabetes in California who may benefit from better glucose control through the use of diabetes technology. The study aims to support these youths and their families in using insulin pumps and monitoring devices more effectively.
What is being tested?
The DREAM intervention, which stands for Device Use Reimagined Through Education And Mentorship, is being tested. It's a virtual peer group program designed to encourage Latinx adolescents with T1D to use diabetes technology more frequently.
What are the potential side effects?
Since this trial focuses on education and mentorship rather than medication or medical procedures, there are no direct side effects related to drugs or surgical interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a teenager with Type 1 Diabetes and get my care at UCSF, CHLA, or UC Davis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adolescent In Person Event Evaluation
Adolescent Online Group Evaluation
Adolescent Phase 2 Intervention Survey - "Feedback Survey"
+7 moreSecondary study objectives
Adolescent BenPump/Pod & BurPump/Pod
Adolescent Benefits and Burdens of CGM (BenCGM & BurCGM)
Adolescent Diabetes Distress Scale (DDS)
+6 moreOther study objectives
Diabetes Technology Use
Hemoglobin A1c
Number of participants completing rountine appointments
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Virtual peer groups (VPGs)
Six different VPGs topics will be offered on two dates (same topic) every 4-6 weeks, with topics rotating at 4-6 week intervals during their 12-month study participation period.
In-Person Events
Quarterly in-person events will be offered during their 12-month study participation period.
Group II: Comparator GroupActive Control1 Intervention
An equal number of eligible non-enrolled patients at each site will be selected and matched to the enrolled cohort based on age, language, HbA1c, insurance type, and diabetes technology use at a population level.
Find a Location
Who is running the clinical trial?
Children's Hospital Los AngelesOTHER
244 Previous Clinical Trials
5,072,946 Total Patients Enrolled
University of California, DavisOTHER
928 Previous Clinical Trials
4,720,898 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,551 Previous Clinical Trials
15,257,766 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger